Immuron (IMRN) Asset Writedowns and Impairment (2016)
Immuron's Asset Writedowns and Impairment came in at $283,995 for fiscal Q4 2024 (quarter ended Jun 30, 2024).
Powered by 
Analysis
Immuron (IMRN) Asset Writedowns and Impairment (2016) Analysis & Trends
For FY2024 (ended Jun 30, 2024), Immuron's Asset Writedowns and Impairment was $282,626.
- Going back by fiscal year, Asset Writedowns and Impairment was $287,008 in FY2023 and -$556,162 in FY2021.
- The fiscal Q4 2024 figure represents the lowest quarterly Asset Writedowns and Impairment since fiscal Q4 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn |
| 10 | Immuron | 7.13 Mn | -10.02 Mn | - |
API Access
Immuron Asset Writedowns and Impairment API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=IMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-writedowns-and-impairment", "ticker": "IMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=IMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();